ConclusionsDespite the paucity of oncology-specific research, cpoe should be used in outpatient chemotherapy delivery to reduce chemotherapy-related medication errors. Adoption by clinicians will be enhanced by cpoe processes that complement current practice and workflow processes.
KEY WORDSComputerized prescriber order entry, outpatients, systematic review
BACKGROUNDChemotherapy is an important type of treatment in the fight against many cancers. The very nature of chemotherapy's toxicity profile also creates potential for harm-and possibly death-if chemotherapy is not ordered, prepared, dispensed, and administered cautiously by members of the health care team.Medication errors can occur anywhere during the medication process from ordering to administration, and errors can compromise patient safety 1,2 . A Canadian study 3 estimated that 7.5% of patients admitted to acute care hospitals in Canada in 2000 experienced at least 1 adverse event. Drug-related adverse events were the second most common type of event, accounting for approximately 24% of all adverse events.Medication errors in oncology can be particularly serious, given the narrow therapeutic window and the high toxicities of antineoplastic drugs 4,5 . In a study conducted by Leape et al. 6 of adverse drug events, 39% of errors occurred in the physician order phase, with drug dosing accounting for 28% of all errors. Specific to chemotherapy, Gandhi et al. 7 revealed that the most common source of error was within the order phase and that, compared with non-chemotherapy medication errors, chemotherapy
ABSTRACT
Background